Company
United StatesConcord Biomedical Science and Emerging Technologies, Inc., Lexington, MA – FDA Inspections
Inspection records and compliance data for Concord Biomedical Science and Emerging Technologies, Inc. in Lexington, MA. 4 FDA inspections on record, 1 Form 483, last inspected January 14, 2025.
Company Profile
This profile covers Concord Biomedical Science and Emerging Technologies, Inc. based in Lexington, MA, United States.
FDA Inspection History
- FDA inspections
- 4
- OAI
- 0
- VAI
- 1
- NAI
- 0
- Unclassified
- 3
- Form 483s
- 1
- Warning letters
- 0
First inspected July 28, 2017. Last inspected January 14, 2025.
Most cited issue areas
- Conduct: in accordance with protocol1 inspection
- Study director: transfer of data to archives1 inspection
FDA inspections (4)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| January 14, 2025 | Not classified | Human Drugs | 1262945 |
| June 28, 2023 | Not classified | Biologics | 1210897 |
| May 23, 2019 | VAI | Medical Devices & Rad Health · Project Evaluation: Devices | 1092985 |
| July 28, 2017 | Not classified | Medical Devices & Rad Health | 1020845 |
FDA documents
Form 483s (1)
EIRs (1)
People (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Englewood Hospital and Medical Center IRB
Douglas R Schumacher MD
Jackson-Madison County General Hospital IRB
Pomona Valley Hospital Medical Center IRB #1
Copley Memorial Hospital IRB
Howard University Institutional Review Board
Univ CO Boulder Institutional Review Board
Terry O'reilly, M.D.
Ning Z. Wu, M.D.
AcelRx Pharmaceuticals, Inc.
Company Information
Name
Concord Biomedical Science and Emerging Technologies, Inc.
FEI Number
3006089773
Address
500 Shire Way, Lexington, MA 02421-2300, United States
Country
United States
ID: 3cfb5992-9173-4719-a830-87b6aff3626a